Prevents depression
Tirzepatide The Strongest GLP-1 Option Available Tirzepatide (Zepbound / Mounjaro) targets both GLP-1 and GIP receptors simultaneously a dual agonist mechanism that makes it the most powerful weight loss medication currently available
Rigorous Testing, No Exceptions: As a family business, we keep costs low and pass the savings directly to you
Following administration in animal models: BPC-157 demonstrates rapid systemic distribution within 15-30 minutes with unusual oral bioavailability TB-500 shows tissue-specific accumulation with preferential uptake in injured areas GHK-Cu exhibits copper-mediated transport and gene-modulating tissue binding KPV utilizes PepT1 transporter-mediated uptake with enhanced delivery to inflamed tissues Combined formulation provides immediate, sustained, and targeted bioactivity across multiple mechanisms Distribution studies suggest that injury sites and inflamed tissues tend to concentrate multiple components through different mechanisms BPC-157 through injury-site targeting, TB-500 through actin-rich repair zones, GHK-Cu through copper-dependent pathways, and KPV through upregulated PepT1 in inflammation, potentially enhancing local therapeutic effects
Do not combine
Sermorelin stimulates pituitary GH release, deepening slowwave (NREM) sleep but may modestly suppress REM, whereas Ipamorelin produces a more balanced increase in both deep and REM phases with fewer cortisol spikes